Mutations presented The point that, as described below, CLL therapy is predicated within the existence or absence of these mutations. The present consensus is the fact, besides clonal mutations, subclonal mutations which has a variant allelic frequency starting from five to 10% (and so below the edge of detection by https://aiveni308dlu6.wikissl.com/user